Business Wire
30 Sept 2026, 05:00 UTC · 2h ago
Almirall Advances Skin Science and Shares New Evidence Across Its Dermatology Portfolio at EADV 2026
Verdict
Headline takes no side. We score ALM +0.40 — moderately bullish.
- Expected · ALM
+0.40moderately bullish
−1 bearish0bullish +1More positive than 68% of ticker scores this week
- Actual




